SK pharmteco doubles viral vector production capacity in Europe

Yposkesi, SK pharmteco’s clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes its second bioproduction facility and doubles its manufacturing footprint to 10,000m2, one of the largest in Europe Operation of the second facility to kick…